EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Paramyxoviruses: Pathogenesis, Vaccines, Antivirals, and Prototypes for Pandemic Preparedness

W Paul Duprex iD, Rebecca Ellis Dutch

The Journal of Infectious Diseases · 18.10.2023 · 228 (Supplement_6) · S390-S397

DOI: 10.1093/infdis/jiad123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 18.10.2023. Verfasst von W Paul Duprex und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Research. Hauptthemen laut MEDLINE: Nipah Virus, Vaccines. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, Coalition for Epidemic Preparedness Innovations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Paramyxoviridae family includes established human pathogens such as measles virus, mumps virus, and the human parainfluenza viruses; highly lethal zoonotic pathogens such as Nipah virus; and a number of recently identified agents, such as Sosuga virus, which remain poorly understood. The high human-to-human transmission rate of paramyxoviruses such as measles virus, high case fatality rate associated with other family members such as Nipah virus, and the existence of poorly characterized zoonotic pathogens raise concern that known and unknown paramyxoviruses have significant pandemic potential. In this review, the general life cycle, taxonomic relationships, and viral pathogenesis are described for paramyxoviruses that cause both systemic and respiratory system–restricted infections. Next, key gaps in critical areas are presented, following detailed conversations with subject matter experts and based on the current literature. Finally, we present an assessment of potential prototype pathogen candidates that could be used as models to study this important virus family, including assessment of the strengths and weaknesses of each potential prototype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nipah VirusVaccinesHumansPandemicsParamyxoviridaeAntiviral Agents

Stichwörter der Autor:innen

pandemic preparednessparamyxovirusprototype pathogenszoonosis

Substanzen

VaccinesAntiviral Agents

Autor:innen und Institutionen

  • Center for Vaccine Research.
  • Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pennsylvania.
  • Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington.

ORCID-Profile: W Paul Duprex

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • Coalition for Epidemic Preparedness Innovations
  • Henry Hillman Family Foundation

Zitieren

APA

Duprex, W. P., & Dutch, R. E. (2023). Paramyxoviruses: Pathogenesis, Vaccines, Antivirals, and Prototypes for Pandemic Preparedness. The Journal of Infectious Diseases, 228(Supplement_6), S390-S397. https://doi.org/10.1093/infdis/jiad123

Vancouver

Duprex WP, Dutch RE. Paramyxoviruses: Pathogenesis, Vaccines, Antivirals, and Prototypes for Pandemic Preparedness. The Journal of Infectious Diseases. 2023;228(Supplement_6):S390-S397. doi:10.1093/infdis/jiad123

BibTeX
@article{Duprex2023,
  author = {Duprex, W Paul and Dutch, Rebecca Ellis},
  title = {Paramyxoviruses: Pathogenesis, Vaccines, Antivirals, and Prototypes for Pandemic Preparedness},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  volume = {228},
  number = {Supplement_6},
  pages = {S390--S397},
  doi = {10.1093/infdis/jiad123}
}
Kostenlos starten →